We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
-1.42%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$54.9M
(+17%)
Cap. Flow
+$65.4M
Cap. Flow
% of AUM
17.05%
Top 10 Holdings %
Top 10 Hldgs %
73.72%
Holding
34
New
13
Increased
12
Reduced
3
Closed
3
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$12.5M |
| 2 |
Zimmer Biomet
ZBH
|
+$9.31M |
| 3 |
Integer Holdings
ITGR
|
+$9.1M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
+$8.13M |
| 5 |
ICU Medical
ICUI
|
+$6.97M |
Top Sells
| 1 |
Haemonetics
HAE
|
+$12.1M |
| 2 |
NovoCure
NVCR
|
+$9.64M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$5.82M |
| 4 |
Medtronic
MDT
|
+$2.09M |
| 5 |
Quest Diagnostics
DGX
|
+$1.43M |
Sector Composition
| 1 | Healthcare | 85.81% |
| 2 | Industrials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $46.4M | 12.09% |
4,225,000
+300,000
| +8% | +$3.08M |
|
|
2
Medtronic
MDT
$107B
| $43.4M | 11.32% |
400,000
-20,000
| -5% | -$2.09M |
|
3
Bio-Rad Laboratories Class A
BIO
$8.05B
| $38.3M | 9.97% |
115,000
+15,000
| +15% | +$4.89M |
|
4
Pacira BioSciences
PCRX
$1.01B
| $29.5M | 7.69% |
775,000
+150,000
| +24% | +$5.99M |
|
|
PTLA
5
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $26.8M | 6.99% |
1,000,000
+445,000
| +80% | +$12.5M |
|
|
6
Zimmer Biomet
ZBH
$18.1B
| $22M | 5.72% |
164,800
+72,100
| +78% | +$9.31M |
|
7
AtriCure
ATRC
$1.8B
| $21.2M | 5.52% |
850,000
+175,000
| +26% | +$5M |
|
8
Lantheus
LNTH
$6.84B
| $18.8M | 4.9% |
750,000
+20,000
| +3% | +$492K |
|
|
9
Quest Diagnostics
DGX
$23.2B
| $18.7M | 4.88% |
175,000
-13,900
| -7% | -$1.43M |
|
|
SRCL
10
DELISTED
Stericycle Inc
SRCL
| $17.8M | 4.64% |
350,000
-125,000
| -26% | -$5.82M |
|
|
HOLX
11
DELISTED
Hologic
HOLX
| $14.1M | 3.68% |
280,000
+5,000
| +2% | +$246K |
|
12
Rigel Pharmaceuticals
RIGL
$771M
| $10.2M | 2.67% |
547,500
| – | – |
|
|
CMD
13
DELISTED
Cantel Medical Corporation
CMD
| $10.1M | 2.63% |
135,000
+20,000
| +17% | +$1.7M |
|
|
CORV
14
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $9M | 2.35% |
4,500,000
+1,150,000
| +34% | +$2.33M |
|
|
15
Integer Holdings
ITGR
$3.38B
| $8.69M | 2.26% |
+115,000
| New | +$9.1M |
|
|
HMSY
16
DELISTED
HMS Holdings Corp.
HMSY
| $7.75M | 2.02% |
+225,000
| New | +$8.13M |
|
17
United Therapeutics
UTHR
$22.5B
| $5.98M | 1.56% |
+75,000
| New | +$6.04M |
|
|
18
ICU Medical
ICUI
$4.05B
| $5.59M | 1.46% |
+35,000
| New | +$6.97M |
|
19
Phreesia
PHR
$673M
| $4.85M | 1.26% |
+200,000
| New | +$5.27M |
|
|
OPTN
20
DELISTED
OptiNose
OPTN
| $4.72M | 1.23% |
+45,000
| New | +$4.49M |
|
21
RadNet
RDNT
$4.95B
| $4.67M | 1.22% |
+325,000
| New | +$4.73M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $4.54M | 1.18% |
52,864
+2,864
| +6% | +$217K |
|
|
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.36M | 0.88% |
3,000,000
| – | – |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.88M | 0.75% |
+25,000
| New | +$3.79M |
|
|
STRM
25
DELISTED
Streamline Health Solutions
STRM
| $2.28M | 0.59% |
140,000
| – | – |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU